| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000273203.1 |
Ponatinib |
Brain lower grade glioma |
0.040957089 |
Resistant |
| ENSG00000273203.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.012881368 |
Resistant |
| ENSG00000273203.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.034617048 |
Sensitive |
